The one tumor with suspected MSI based on TMA screening that turned out MMR intact on large section analysis was a pancreatic NET G3 with strongly attenuated PMS2 immunoreactivity throughout the majority of the tumor, but PMS2 expression was still retained and the other analyzed MMR proteins were inconspicuous. The gene discussed is PMS2; the disease is pancreatic neuroendocrine tumor.